Rajasekaran J, Krishnamurthy H, Bosco J, Jayaraman V, Krishna K, Wang T
Microorganisms. 2024; 12(9).
PMID: 39338471
PMC: 11434369.
DOI: 10.3390/microorganisms12091797.
Al-Failakawi A, Al-Jarallah A, Rao M, Khan I
Biomolecules. 2024; 14(9).
PMID: 39334888
PMC: 11430412.
DOI: 10.3390/biom14091122.
Zhao Y, Si S, Ren Y, Wu X, Zhang Z, Tian Y
Anim Nutr. 2024; 18:177-190.
PMID: 39263442
PMC: 11388669.
DOI: 10.1016/j.aninu.2024.04.022.
Wang L, Nabi F, Zhang X, Zhou G, Shah Q, Li S
Probiotics Antimicrob Proteins. 2024; .
PMID: 39090454
DOI: 10.1007/s12602-024-10336-x.
Rakotoarivelo V, Mayer T, Simard M, Flamand N, Di Marzo V
Molecules. 2024; 29(14).
PMID: 39064959
PMC: 11279428.
DOI: 10.3390/molecules29143381.
Mathematical Modeling of Vedolizumab Treatment's Effect on Microbiota and Intestinal Permeability in Inflammatory Bowel Disease Patients.
DAmbrosio A, Altomare A, Boscarino T, Gori M, Balestrieri P, Putignani L
Bioengineering (Basel). 2024; 11(7).
PMID: 39061792
PMC: 11274165.
DOI: 10.3390/bioengineering11070710.
Soybean Bioactive Peptide Supplementation Affects the Intestinal Immune Antioxidant Function, Microbial Diversity, and Reproductive Organ Development in Roosters.
Wei Y, Zhao X, Xu T, Liu Z, Zuo Y, Zhang M
Animals (Basel). 2024; 14(13).
PMID: 38998068
PMC: 11240439.
DOI: 10.3390/ani14131954.
A derivative of 3-(1,3-diarylallylidene)oxindoles inhibits dextran sulfate sodium-induced colitis in mice.
Jeong Y, Lee H, Park S, Lee J, Kim L, Kim H
Pharmacol Rep. 2024; 76(4):851-862.
PMID: 38916850
PMC: 11294400.
DOI: 10.1007/s43440-024-00616-2.
Colonic Epithelial Permeability to Ions Is Restored after Vedolizumab Treatment and May Predict Clinical Response in Inflammatory Bowel Disease Patients.
Cicala M, Gori M, Balestrieri P, Altomare A, Tullio A, Di Cola S
Int J Mol Sci. 2024; 25(11).
PMID: 38892004
PMC: 11172326.
DOI: 10.3390/ijms25115817.
Protective effect of zinc gluconate on intestinal mucosal barrier injury in antibiotics and LPS-induced mice.
Wang Y, Xiao J, Wei S, Su Y, Yang X, Su S
Front Microbiol. 2024; 15:1407091.
PMID: 38855764
PMC: 11157515.
DOI: 10.3389/fmicb.2024.1407091.
The barrier-protective effect of β-eudesmol against type 2-inflammatory cytokine-induced tight junction disassembly in airway epithelial cells.
Tharabenjasin P, Moonwiriyakit A, Sontikun J, Timpratueang K, Kuno S, Aiebchun T
PLoS One. 2024; 19(4):e0302851.
PMID: 38687777
PMC: 11060601.
DOI: 10.1371/journal.pone.0302851.
Profiling the colonic mucosal response to fecal microbiota transplantation identifies a role for GBP5 in colitis in humans and mice.
Luu L, Pandey A, Paramsothy S, Ngo C, Castano-Rodriguez N, Liu C
Nat Commun. 2024; 15(1):2645.
PMID: 38531874
PMC: 10965925.
DOI: 10.1038/s41467-024-46983-5.
Adenosine in Intestinal Epithelial Barrier Function.
Stepanova M, Aherne C
Cells. 2024; 13(5.
PMID: 38474346
PMC: 10930693.
DOI: 10.3390/cells13050381.
MUC13 negatively regulates tight junction proteins and intestinal epithelial barrier integrity via protein kinase C.
Segui-Perez C, Stapels D, Ma Z, Su J, Passchier E, Westendorp B
J Cell Sci. 2024; 137(5).
PMID: 38345099
PMC: 10984281.
DOI: 10.1242/jcs.261468.
Trichinella spiralis cathepsin L damages the tight junctions of intestinal epithelial cells and mediates larval invasion.
Liu R, Meng X, Li C, Lin X, Xu Q, Xu H
PLoS Negl Trop Dis. 2023; 17(12):e0011816.
PMID: 38048314
PMC: 10721182.
DOI: 10.1371/journal.pntd.0011816.
A Colonic Organoid Model Challenged with the Large Toxins of TcdA and TcdB Exhibit Deregulated Tight Junction Proteins.
Schneemann M, Heils L, Moos V, Weiss F, Krug S, Weiner J
Toxins (Basel). 2023; 15(11).
PMID: 37999506
PMC: 10674794.
DOI: 10.3390/toxins15110643.
HOIL1 Regulates Group 3 Innate Lymphoid Cells in the Colon and Protects against Systemic Dissemination, Colonic Ulceration, and Lethality from Citrobacter rodentium Infection.
Hartley V, Qaqish A, Wood M, Studnicka B, Iwai K, Liu T
J Immunol. 2023; 211(12):1823-1834.
PMID: 37902285
PMC: 10841105.
DOI: 10.4049/jimmunol.2300351.
Healing of the epithelial barrier in the ileum is superior to endoscopic and histologic remission for predicting major adverse outcomes in ulcerative colitis.
Rath T, Atreya R, Bodenschatz J, Uter W, Geppert C, Vitali F
Front Med (Lausanne). 2023; 10:1221449.
PMID: 37881628
PMC: 10595008.
DOI: 10.3389/fmed.2023.1221449.
Modulation of intestinal IL-37 expression and its impact on the epithelial innate immune response and barrier integrity.
Krohn L, Azabdaftari A, Heuberger J, Hudert C, Zilbauer M, Breiderhoff T
Front Immunol. 2023; 14:1261666.
PMID: 37799712
PMC: 10548260.
DOI: 10.3389/fimmu.2023.1261666.
Intestinal Barrier Dysfunction in Inflammatory Bowel Disease: Underpinning Pathogenesis and Therapeutics.
Dunleavy K, Raffals L, Camilleri M
Dig Dis Sci. 2023; 68(12):4306-4320.
PMID: 37773554
PMC: 10798146.
DOI: 10.1007/s10620-023-08122-w.